Ignite Creation Date:
2024-05-05 @ 11:27 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00045032
Status:
COMPLETED
Last Update Posted:
2017-04-27
First Post:
2002-09-06
Brief Title:
Herceptin Trastuzumab in Treating Women With Human Epidermal Growth Factor Receptor HER 2-Positive Primary Breast Cancer
Sponsor:
Organization:
Hoffmann-La Roche